We are live on
!
Find out more
AAMU
AEGON Asset Management (UK) Portfolio holdings
AUM
$9.38B
1-Year Est. Return
48.94%
This Fund
S&P 500
This Quarter
Est. Return
+11.13%
1 Year Est. Return
+48.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$453M
(+7.9%)
Cap. Flow
-$23.3M
Cap. Flow
% of AUM
-0.38%
Top 10 Holdings %
Top 10 Hldgs %
44.26%
Holding
167
New
4
Increased
35
Reduced
91
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$53.7M |
| 2 |
Idexx Laboratories
IDXX
|
+$30.1M |
| 3 |
Sherwin-Williams
SHW
|
+$29.3M |
| 4 |
Watsco Inc
WSO
|
+$24.4M |
| 5 |
TransUnion
TRU
|
+$23.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$53.5M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$43.9M |
| 3 |
Packaging Corp of America
PKG
|
+$29.6M |
| 4 |
MetLife
MET
|
+$29M |
| 5 |
Visa
V
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.34% |
| 2 | Healthcare | 12.53% |
| 3 | Financials | 10.99% |
| 4 | Industrials | 8.89% |
| 5 | Consumer Discretionary | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Clorox
CLX
$12.7B
| $143K | ﹤0.01% |
897
| – | – |
|
152
Verisk Analytics
VRSK
$25.1B
| $6K | ﹤0.01% |
25
| – | – |
|
153
Nasdaq
NDAQ
$52.3B
| $5K | ﹤0.01% |
92
| – | – |
|
154
Viatris
VTRS
$20.6B
| $5K | ﹤0.01% |
531
| – | – |
|
155
Ball Corp
BALL
$17B
| $4K | ﹤0.01% |
69
| – | – |
|
156
Edwards Lifesciences
EW
$51.6B
| $4K | ﹤0.01% |
45
| – | – |
|
157
Trex
TREX
$4.89B
| $4K | ﹤0.01% |
65
+19
| +41% | +$1.06K |
|
158
Cognex
CGNX
$11.9B
| $3K | ﹤0.01% |
46
| – | – |
|
|
NVO
159
Novo Nordisk
NVO
$196B
| $3K | ﹤0.01% |
36
| – | – |
|
160
Alnylam Pharmaceuticals
ALNY
$29.3B
| $2K | ﹤0.01% |
9
| – | – |
|
|
EXAS
161
DELISTED
Exact Sciences
EXAS
| – | – |
-33
| Closed | -$2K |
|
162
Gray Television
GTN
$441M
| – | – |
-114,898
| Closed | -$1M |
|
163
Mastercard
MA
$500B
| – | – |
-65,086
| Closed | -$23.6M |
|
164
Pinduoduo
PDD
$130B
| – | – |
-69,387
| Closed | -$5.27M |
|
165
Sea Limited
SE
$68.3B
| – | – |
-46,370
| Closed | -$4.01M |
|
166
Waters Corp
WAT
$38.9B
| – | – |
-5,373
| Closed | -$1.66M |
|
|
EVBG
167
DELISTED
Everbridge, Inc. Common Stock
EVBG
| – | – |
-284,946
| Closed | -$9.87M |
|
Similar funds
NPT
AC
PVI
WPL
RCM
IAA
RCMNY
SCM
AEGON Asset Management (UK)'s Q2 2023 Portfolio in Review
As of Q2 2023, AEGON Asset Management (UK) held 167 positions worth $6.18B, up 7.9% from $5.73B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
AEGON Asset Management (UK)'s Q2 2023 filing shows 4 new, 35 increased, 91 reduced and 7 closed positions. Its largest new stake was Sherwin-Williams: 124,565 shares worth $33.1M. The largest sale was Walt Disney, an estimated $53.5M.
By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 37% a quarter earlier, followed by Healthcare and Financials.
- AEGON Asset Management (UK)'s largest Q2 2023 buy was Sherwin-Williams: 124,565 shares worth $33.1M.
- AEGON Asset Management (UK) added most to Merck in Q2 2023, an estimated $53.7M increase.
- AEGON Asset Management (UK)'s biggest Q2 2023 reduction was Walt Disney, cutting an estimated $53.5M.
- AEGON Asset Management (UK) fully exited Mastercard in Q2 2023, selling an estimated $23.6M.
- AEGON Asset Management (UK)'s ten largest holdings make up 44% of its $6.18B portfolio in Q2 2023.
- AEGON Asset Management (UK) opened 4 new positions and closed 7 in Q2 2023.
- AEGON Asset Management (UK)'s portfolio value rose 7.9% quarter-over-quarter to $6.18B.
Based on AEGON Asset Management (UK)'s 13F filing for Q2 2023, filed 28 Jul 2023.